Home

Johnson & Johnson (JNJ)

155.46
+0.43 (0.28%)
NYSE · Last Trade: Jun 9th, 12:33 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Rep. Gilbert Ray Cisneros Has Bought Up to $410K Worth Of Johnson & Johnson Stock: Here's What You Should Knowbenzinga.com
Via Benzinga · June 9, 2025
3 Top Dividend Stocks Analysts Are Bullish on Right Now
With earnings season coming to an end, investors are looking for new catalysts; here are three blue-chip companies with strong analyst support
Via MarketBeat · June 6, 2025
12 Analysts Have This To Say About Johnson & Johnsonbenzinga.com
Via Benzinga · June 5, 2025
Dr Reddy's And Alvotech Join Hands To Develop Biosimilar For Merck's Blockbuster Cancer Drugbenzinga.com
Alvotech and Dr. Reddy's will co-develop a biosimilar to Keytruda, aiming to expand global access to cancer treatment alternatives.
Via Benzinga · June 5, 2025
AnaptysBio's Arthritis Drug Matches Top Therapies In Phase 2 Trial, Analyst Sees Turning Pointbenzinga.com
Rosnilimab met key RA trial goals, with sustained clinical responses and safety benefits, prompting an analyst upgrade and price target hike to $38.
Via Benzinga · June 4, 2025
P/E Ratio Insights for Johnson & Johnsonbenzinga.com
Via Benzinga · May 28, 2025
Johnson & Johnson Highlights Multiple Blood Cancer Trial Data At ASCO Presentationbenzinga.com
Johnson & Johnson shared positive ASCO 2025 results, including improved survival and remission in prostate and multiple myeloma patients.
Via Benzinga · June 3, 2025
5 Cheap Stocks to Buy in Junefool.com
These stocks are ready for a summer surge.
Via The Motley Fool · June 3, 2025
Top 3 Reasons Savvy Investors Are Buying Johnson & Johnson Stock While Others Panic Over Lawsuitstalkmarkets.com
For long-term investors looking for both stability and innovation in the healthcare space, JNJ is a rare combination of both.
Via Talk Markets · May 31, 2025
3 Elite High-Yield Dividend Stocks Down 8% to 27% That Have Hiked Their Payouts for More than 50 Years in a Rowfool.com
Via The Motley Fool · May 29, 2025
Michael Mahoney Turned Boston Scientific Into A Medical Tech Empireinvestors.com
Michael Mahoney's grandfather was a cardiac surgeon — so his first career plan was to become a doctor. Mahoney didn't give up — he adjusted.
Via Investor's Business Daily · May 29, 2025
Why Is Teva Stock Trading Higher On Tuesday?benzinga.com
Teva starts IND-enabling studies for BD9, a dual-target therapy for asthma and atopic dermatitis, under license from Biolojic Design.
Via Benzinga · May 27, 2025
Why Dan Loeb Just Made Kenvue One Of His Top Holdingsbenzinga.com
Activist investor Dan Loeb's Third Point LLC acquired a significant stake in consumer health company Kenvue Inc. in Q1 2025.
Via Benzinga · May 27, 2025
1 Top Dividend Stock to Buy for a Lifetime of Passive Incomefool.com
Via The Motley Fool · May 27, 2025
Johnson & Johnson (NYSE:JNJ) – A Reliable Dividend Stock Worth Consideringchartmill.com
Johnson & Johnson (NYSE:JNJ) offers a strong dividend yield, consistent growth, and solid profitability, making it a compelling choice for income investors.
Via Chartmill · May 26, 2025
Investing for Passive Income? Here's What History Says About the Stability of Dividend King Stocks.fool.com
Via The Motley Fool · May 25, 2025
Generating Passive Income: 3 Top Dow Dividend Stocks to Buy for 2025 and Beyondfool.com
Via The Motley Fool · May 24, 2025
Elon Musk Commits to Tesla. Is That a Good Thing?fool.com
Via The Motley Fool · May 23, 2025
Value Investing Is Not Dead - It Just Got Smarterbenzinga.com
Via Benzinga · May 23, 2025
This Healthy High-Yielding Dividend Stock Just Increased Its Payment for the 48th Year in a Rowfool.com
Via The Motley Fool · May 23, 2025
3 Buy-and-Hold Stocks Long-Term Investors Can Love in Any Market
For buy-and-hold investors looking for some quality names to navigate a turbulent market, here are three stocks to consider
Via MarketBeat · May 22, 2025
Apple, Nvidia, GM: CEOs Are Talking About Being American-Made Againbenzinga.com
US companies are reshoring manufacturing operations & investing billions in the country, led by Apple & Nvidia for tech, J&J & Eli Lilly for healthcare, Anheuser-Busch for beer, & Cra-Z-Art for toys. Detroit & beyond are benefiting from this trend.
Via Benzinga · May 20, 2025
Market Whales and Their Recent Bets on JNJ Optionsbenzinga.com
Via Benzinga · May 19, 2025
Meet the Warren Buffett Investment That's Gained 5,502,284% and Looks Set to Soar Even Higherfool.com
Warren Buffett has had a lot of successful investments, but one in particular has crushed the stock market time and again.
Via The Motley Fool · May 18, 2025
3 Magnificent Stocks That Are Passive Income Machinesfool.com
Via The Motley Fool · May 17, 2025